<DOC>
	<DOC>NCT02680665</DOC>
	<brief_summary>This Study is intended to evaluate the safety and effectiveness of Ameparomo Capsules 250 mg under actual medical practice.</brief_summary>
	<brief_title>Ameparomo Capsules 250 mg Drug Use Investigation</brief_title>
	<detailed_description />
	<mesh_term>Amebiasis</mesh_term>
	<mesh_term>Dysentery, Amebic</mesh_term>
	<criteria>Patients with no history of using this product No exclusion criteria are set out in this study.</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>